Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care

•Download as PPT, PDF•

3 likes•74 views

PVI, PeerView Institute for Medical Education

Neal D. Shore, MD, FACS, Arjun Balar, MD, and Noah M. Hahn, MD, discuss bladder cancer in this CME activity titled "Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care." For the full presentation, downloadable Practice Aids, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2Q6c1U4. CME credit will be available until June 5, 2020.

Health & Medicine

Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care

Co-Chairs, Stephen Salloway, MD, MS, and Sharon J. Sha, MD, MS, prepared useful Practice Aids pertaining to Alzheimer's disease for this CME/MOC/NCPD/AAPA activity titled “Preparing Your Practice for the New Era of Amyloid-Targeting Therapies in Alzheimer's Disease: Expert Insights on Key Evidence, Administrative and Clinical Considerations, and Best Practices for Individualized, Patient-Centered Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3twjpAt. CME/MOC/NCPD/AAPA credit will be available until June 19, 2025.

Preparing Your Practice for the New Era of Amyloid-Targeting Therapies in Alz...

PVI, PeerView Institute for Medical Education

Co-Chairs, Stephen Salloway, MD, MS, and Sharon J. Sha, MD, MS, discuss Alzheimer's disease in this CME/MOC/NCPD/AAPA activity titled “Preparing Your Practice for the New Era of Amyloid-Targeting Therapies in Alzheimer's Disease: Expert Insights on Key Evidence, Administrative and Clinical Considerations, and Best Practices for Individualized, Patient-Centered Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3twjpAt. CME/MOC/NCPD/AAPA credit will be available until June 19, 2025.

Candid Conversations on Modern Urothelial Cancer Management: Personalizing Pa...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Andrea Necchi, MD, Matthew D. Galsky, MD, Shilpa Gupta, MD, and Michiel S. van der Heijden, MD, PhD, prepared useful Practice Aids pertaining to bladder cancer for this CME/MOC/NCPD/AAPA/IPCE activity titled “Candid Conversations on Modern Urothelial Cancer Management: Personalizing Patient Care Using the Latest Evidence and Innovative Therapeutic Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4cDsBog. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.

Candid Conversations on Modern Urothelial Cancer Management: Personalizing Pa...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Andrea Necchi, MD, Matthew D. Galsky, MD, Shilpa Gupta, MD, and Michiel S. van der Heijden, MD, PhD, discuss bladder cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Candid Conversations on Modern Urothelial Cancer Management: Personalizing Patient Care Using the Latest Evidence and Innovative Therapeutic Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4cDsBog. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.

A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection an...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Sumanta Kumar Pal, MD, FASCO, Nizar M. Tannir, MD, FACP, and Tian Zhang, MD, MHS, prepared useful Practice Aids pertaining to renal cell carcinoma for this CME/MOC/NCPD/AAPA/IPCE activity titled “A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection and Sequencing.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3xgpDpY. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 2, 2025.

A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection an...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Sumanta Kumar Pal, MD, FASCO, Nizar M. Tannir, MD, FACP, and Tian Zhang, MD, MHS, discuss renal cell carcinoma in this CME/MOC/NCPD/AAPA/IPCE activity titled “A Roadmap for Modern RCC Care: Navigating Personalized Treatment Selection and Sequencing.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3xgpDpY. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 2, 2025.

Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging S...

PVI, PeerView Institute for Medical Education

Co-Chairs, Amit Bar-Or, MD, FRCPC, and Jiwon Oh, MD, PhD, FRCPC, prepared useful Practice Aids pertaining to multiple sclerosis for this CME/NCPD/CPE/IPCE activity titled “Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging Strategies in MS.” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/IPCE information, and to apply for credit, please visit us at https://bit.ly/3IyZJQh. CME/NCPD/CPE/IPCE credit will be available until June 29, 2025.

Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging S...

PVI, PeerView Institute for Medical Education

Co-Chairs, Amit Bar-Or, MD, FRCPC, and Jiwon Oh, MD, PhD, FRCPC, discuss multiple sclerosis in this CME/NCPD/CPE/IPCE activity titled “Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging Strategies in MS.” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/IPCE information, and to apply for credit, please visit us at https://bit.ly/3IyZJQh. CME/NCPD/CPE/IPCE credit will be available until June 29, 2025.

Chair and Presenter, Manish A. Shah, MD, FASCO, Ronan J. Kelly, MD, MBA, FASCO, and Prof. Dr. Markus Moehler, discuss gastric cancer in this CME/MOC/NCPD/AAPA activity titled “Catalysts for Change in Gastric & GEJ Cancer: Digesting New Evidence & Future Directions of Care With Innovative Immunotherapy & Targeted Platforms.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3VHpl55. CME/MOC/NCPD/AAPA credit will be available until July 2, 2025.

Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer: Exper...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Karim Fizazi, MD, PhD, Pedro C. Barata, MD, MSc, FACP, Kim N. Chi, MD, FRCPC, and Alicia K. Morgans, MD, MPH, discuss prostate cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer: Experts Put the Pressure on Key Evidence and Real-World Strategies to Optimize Patient Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3VqHUKU. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.

Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targ...

PVI, PeerView Institute for Medical Education

Chair and Presenters, Yelena Y. Janjigian*, MD, Shubham Pant, MD, and John Strickler, MD, discuss HER2+ GI malignancies in this CME/MOC/NCPD/AAPA/IPCE activity titled “Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/49K4Qcb. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 30, 2025.

Anticoagulation Therapy in NVAF: A Quality Improvement Initiative

PVI, PeerView Institute for Medical Education

Chair Kun "Kevin" Xiang, MD, PhD, discusses atrial fibrillation in this CME/MOC/NCPD/CPE activity titled “Anticoagulation Therapy in NVAF: A Quality Improvement Initiative.” For the full presentation, downloadable Practice Aids, monograph, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at https://bit.ly/2UoPplb. CME/MOC/NCPD/CPE credit will be available until June 12, 2025.

Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communica...

PVI, PeerView Institute for Medical Education

Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...

PVI, PeerView Institute for Medical Education

Chair, William Anderson, MD, discusses severe asthma in this CME/MOC/NCPD/CPE/AAPA activity titled “Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Severe Asthma Using a Collaborative Approach: Recognition, Referral, and Management in the Era of Targeted Treatment Options.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at https://bit.ly/3IJWFAR. CME/MOC/NCPD/CPE/AAPA credit will be available until June 13, 2025.

Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...

PVI, PeerView Institute for Medical Education

Chair and Presenters Professor Stephen Johnston, MA, PhD, Patrick Neven, MD, PhD, and Joyce O’Shaughnessy, MD, prepared useful Practice Aids pertaining to breast cancer for this CME/MOC/CPD/NCPD/CPE/AAPA activity titled “Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Practical Roadmap for CDK4/6 Inhibition in the Adjuvant Setting.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CPD/NCPD/CPE/AAPA information, and to apply for credit, please visit us at https://bit.ly/49HZ5fH. CME/MOC/CPD/NCPD/CPE/AAPA credit will be available until June 21, 2025.

Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...

PVI, PeerView Institute for Medical Education

Chair and Presenters Professor Stephen Johnston, MA, PhD, Patrick Neven, MD, PhD, and Joyce O’Shaughnessy, MD, discuss breast cancer in this CME/MOC/CPD/NCPD/CPE/AAPA activity titled “Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Practical Roadmap for CDK4/6 Inhibition in the Adjuvant Setting.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CPD/NCPD/CPE/AAPA information, and to apply for credit, please visit us at https://bit.ly/49HZ5fH. CME/MOC/CPD/NCPD/CPE/AAPA credit will be available until June 21, 2025.

Cases in the Community: Optimizing Treatment and Considering Weight Managemen...

PVI, PeerView Institute for Medical Education

Chair, Javier Morales, MD, FACP, FACE, discusses Type 2 diabetes in this CME/CE/AAPA activity titled “Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People with T2DM.” For the full presentation, downloadable Practice Aids, and complete CME/CE/AAPA information, and to apply for credit, please visit us at . CME/CE/AAPA credit will be available until June 11, 2025.

Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...

PVI, PeerView Institute for Medical Education

Chair, Nicole Lamanna, MD, discusses chronic lymphocytic leukemia in this CME activity titled “Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standards, and Innovative BTKi Combinations.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/49Mazi3. CME credit will be available until June 11, 2025.

Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...

PVI, PeerView Institute for Medical Education

Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, discuss Alzheimer’s disease in this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.

Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...

PVI, PeerView Institute for Medical Education

Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.

Adapting HIV Treatment for People With Substance Use Disorder

PVI, PeerView Institute for Medical Education

Chair, Monica Gandhi, MD, MPH, prepared useful Practice Aids pertaining to HIV for this CME/MOC/CE/AAPA activity titled “Adapting HIV Treatment for People With Substance Use Disorder.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CE/AAPA information, and to apply for credit, please visit us at https://bit.ly/49hgPxT. CME/MOC/CE/AAPA credit will be available until June 4, 2025.

Adapting HIV Treatment for People With Substance Use Disorder

PVI, PeerView Institute for Medical Education

Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...

PVI, PeerView Institute for Medical Education

Chair, Carla M. Nester, MD, MSA, FASN, discusses glomerular kidney disease in this CME activity titled “Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evolving Landscape of Glomerular Kidney Disease Management.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3wJPTs1. CME credit will be available until June 4, 2025.

Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?

PVI, PeerView Institute for Medical Education

Chair and Presenter Rohit Loomba, MD, MHSc, and Alina M. Allen, MD, MS, discuss metabolic dysfunction–associated steatohepatitis in this CME activity titled “Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3O53xMy. CME credit will be available until June 19, 2025.

Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...

PVI, PeerView Institute for Medical Education

Co-Chairs, Prof. Mohamad Mohty, MD, PhD, and Caitlin Costello, MD, discuss refractory multiple myeloma in this CME/CPD activity titled “Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM.” For the full presentation, downloadable Practice Aids, and complete CME/CPD information, and to apply for credit, please visit us at https://bit.ly/3UFL0dt. CME/CPD credit will be available until 5 June 2025.

Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...

PVI, PeerView Institute for Medical Education

Co-Chairs, Doreen J. Addrizzo-Harris, MD, and Cedric "Jamie" Rutland, MD, discuss non-cystic fibrosis bronchiectasis in this CME/MOC/AAPA activity titled “Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understanding Disease Burden, Diagnosing Early, and Looking Toward New Management Options.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at https://bit.ly/3KlxjL9. CME/MOC/AAPA credit will be available until June 19, 2025.

Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...

PVI, PeerView Institute for Medical Education

Co-Chairs Riad Salem, MD, MBA, and Mark Yarchoan, MD, discuss liver cancer in this CME/MOC activity titled “Establishing the Collaborative Benchmark for HCC Care: Critical Discussions Between Interventional Radiologists and Oncologists to Maximize Therapeutic Benefit.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3IOQvQ6. CME/MOC credit will be available until June 14, 2025.

Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...

PVI, PeerView Institute for Medical Education

Co-Chairs, Brett Elicker, MD, and David E. Griffith, MD, ATSF, ACCP, OFRSM, prepared useful Practice Aids pertaining to non-cystic fibrosis bronchiectasis for this CME/MOC activity titled “Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/48WUULu. CME/MOC credit will be available until June 4, 2025.

Breast cancer: Post menopausal endocrine therapy

Dr. Sumit KUMAR

Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options. Diagnosis and Staging The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells. Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions. Treatment Options Endocrine Therapy Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include: Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events. Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen. Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops. Combination Therapies Combining endocrine therapy with other treatments enhances efficacy. Examples include: Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer. Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors. Chemotherapy Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.

Introduction to British pharmacopeia.pptx

taiba qazi

Recently uploaded

Breast cancer: Post menopausal endocrine therapy

Dr. Sumit KUMAR

Introduction to British pharmacopeia.pptx

taiba qazi

District Residency Programme (DRP) for PGs in India.pptx

CommunityMedicine46

KENT'S REPERTORY by dr niranjan mohanty.pptx

SravsPandu1

How to Control Your Asthma Tips by gokuldas hospital.

Gokuldas Hospital

STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7

shruti jagirdar

Unit 4: MRA 103T Regulatory affairs This guideline is directed principally toward new Molecular Entities that are likely to have significant use in the elderly, either because the disease intended to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or because the population to be treated is known to include substantial numbers of geriatric patients (e.g., hypertension).

What is Obesity? How to overcome Obesity?

Healthmedsrx.com

RESPIRATORY DISEASES by bhavya kelavadiya

Bhavyakelawadiya

biomechanics of running. Dr.dhwani.pptx

Dr. Dhwani kawedia

The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro

Kanhu Charan

Giloy in Ayurveda - Classical Categorization and Synonyms

Planet Ayurveda

Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.

Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...

Jim Jacob Roy

Ageing, the Elderly, Gerontology and Public Health

phuakl

Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai

Mobile Problem

Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf

Osvaldo Bernardo Muchanga

GASTROINTESTINAL INFECTIONS AND GASTRITIS Osvaldo Bernardo Muchanga Gastrointestinal Infections GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission. Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others. These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others. The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition). To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH. Gastritis and Gastric Health Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans. Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively. In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively. Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.

Nutritional deficiency disorder in Child

Bhavyakelawadiya

Cervical Disc Arthroplasty ORSI 2024.pptx

LEFLOT Jean-Louis

What are the different types of Dental implants.

Gokuldas Hospital

Are you looking for a long-lasting solution to your missing tooth? Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.

acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals

MuskanShingari

Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf

MuhammadMuneer49

Recently uploaded (20)

Breast cancer: Post menopausal endocrine therapy

Introduction to British pharmacopeia.pptx

District Residency Programme (DRP) for PGs in India.pptx

KENT'S REPERTORY by dr niranjan mohanty.pptx

How to Control Your Asthma Tips by gokuldas hospital.

STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7

What is Obesity? How to overcome Obesity?

RESPIRATORY DISEASES by bhavya kelavadiya

biomechanics of running. Dr.dhwani.pptx

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro

Giloy in Ayurveda - Classical Categorization and Synonyms

Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...

Ageing, the Elderly, Gerontology and Public Health

Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai

Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf

Nutritional deficiency disorder in Child

Cervical Disc Arthroplasty ORSI 2024.pptx

What are the different types of Dental implants.

acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals

Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf

Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care

Recommended

Recommended

More Related Content

More from PVI, PeerView Institute for Medical Education

More from PVI, PeerView Institute for Medical Education (20)

Recently uploaded

Recently uploaded (20)